The long simmering discussion over whether manufacturers of Covid-19 vaccines should waive their intellectual property (IP) rights in hope of giving more people access to...
US Covid-19 vaccine manufacturer Moderna said it is planning to make major renovations at its Norwood, Massachusetts, mRNA production site with the aim of more than...
With a positive vote of both the European Parliament and the Council at the end of April, the EU has ratified the Trade and Cooperation Agreement establishing the terms...
The EU has clinched the deal with vaccine team Pfizer/BioNtech hinted at in mid-April. European Commmission president Ursula von der Leyen late last week informed member...
Swiss CDMO Lonza and US vaccine maker Moderna have extended and deepened their collaboration on the US biotech’s mRNA- based Covid-19 shot. The new agreement, which calls...
US catalyst and technology company W. R. Grace has won two separate contracts to supply its Unipol PP process.
Azelis has entered into an agreement to buy US-based Vigon International, expanding its footprint in the life sciences sector. Financial details of the transaction...
US biotech Exelixis has acquired GamaMabs Pharma’s anti-Müllerian hormone receptor 2 (AMHR2) technology. Antibody-drug conjugates (ADCs) targeting AMHR2 could provide...
Europe wants to become the world’s first climate-neutral continent by 2050 and decouple its economic growth from the consumption of natural resources – this is what the...
Recent studies show that contract manufacturers for the pharmaceutical industry, so-called CDMOs (contract development and manufacturing organizations), have so far been...
EU Annex 1 which specifies guidance for the manufacture of sterile medicinal products is currently in the process of being rewritten. The current 16-page document will be...
The European Chemical Industry has set out on an ambitious path to become carbon neutral.
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | Twitter
May 19, 2021 | 4 p.m. (CEST) / 10 a.m. (EDT)
Join the live webinar series and get a deep insight into the newest developments from Lanxess' Business Units which will highlight innovative product solutions.
China presents both challenges and opportunities to international businesses.